Answers are grounded in this paper and cite their sources.
A copolymer, poly(L‐lactide)‐g‐poly(N‐vinyl pyrrolidone) (PLLA‐g‐PVP) was prepared with poly(L‐lactide) (PLLA) and N‐vinyl pyrrolidone in the presence of methanol as a solvent by γ‐ray irradiation. The structure of PLLA‐g‐PVP was characterized by 1H‐NMR and Fourier transform infrared spectroscopy. The PLLA‐g‐PVP graft ratio calculated by the percentage increase in weight increased with the increase of absorbed dose, and the percentage crystallinity of PLLA‐g‐PVP decreased with increasing graft ratio. The introduction of the poly(N‐vinyl pyrrolidone) chain into PLLA resulted in a decrease in the contact angle of PLLA‐g‐PVP with increasing graft ratio. In vitro degradation testing showed that PLLA‐g‐PVP had a higher degradation rate both in the weight‐loss test and molecular weight measurement because of a lower crystalline percentage and higher hydrophilicity compared to PLLA.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: